![Kerri-Ann Millar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kerri-Ann Millar
No open positions remaining
Profile
Kerri-Ann Millar formerly worked at Flexion Therapeutics, Inc., as Controller from 2014 to 2017 and Cue Biopharma, Inc., as Chief Financial Officer from 2020 to 2025.
Ms. Millar received her undergraduate degree in 1992 from Boston University.
Former positions of Kerri-Ann Millar
| Companies | Position | End |
|---|---|---|
| CUE BIOPHARMA, INC. | Director of Finance/CFO | 13/06/2025 |
| FLEXION THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/09/2017 |
Training of Kerri-Ann Millar
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
95
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cue Biopharma, Inc.
 Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Kerri-Ann Millar
